Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | BACE1 | P56817 | 1/20 | 0.58 |
| ▸ | PPARG | P37231 | 2/20 | 0.52 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21049245 | 0.92 | ACHE (0.67) | ACHEBACE1PPARGGPR132FAAH | |
| SCHEMBL29256074 | 0.92 | ACHE (0.67) | ACHEBACE1PPARGGPR132FAAH | |
| SCHEMBL23647621 | 0.92 | ACHE (0.67) | ACHEBACE1PPARGGPR132FAAH | |
| SCHEMBL27776648 | 0.91 | ACHE (0.58) | ACHEBACE1PPARGGPR132FAAH | |
| SCHEMBL667165 | 0.91 | ACHE (0.65) | ACHEBACE1PPARGGPR132FAAH | |
| SCHEMBL30072208 | 0.91 | ACHE (0.65) | ACHEBACE1PPARGGPR132FAAH | |
| SCHEMBL6129416 | 0.91 | ACHE (0.65) | ACHEBACE1PPARGGPR132FAAH | |
| SCHEMBL15287182 | 0.80 | ACHE (0.49) | ACHEBACE1PPARGGPR132FAAH | |
| SCHEMBL561406 | 0.80 | ACHE (0.49) | ACHEBACE1PPARGGPR132FAAH | |
| SCHEMBL4759937 | 0.80 | ACHE (0.49) | ACHEBACE1PPARGGPR132FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023146984-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2023-08-03 | — | — | WO | claimed |
| EP-4329742-A1 | COMPOSITIONS COMPRISING EPA AND METHODS OF USING THE SAME FOR TREATING AND/OR PREVENTING ENDOTHELIAL DYSFUNCTION IN A SUBJECT | Amarin Pharmaceuticals Ireland Limited (IE) | 2024-03-06 | — | — | EP | disclosed |
| WO-2023146984-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2023-08-03 | — | — | WO | disclosed |
| WO-2018148342-A1 | COMPRESSED OPEN FLOW ASSAY AND USE | ESSENLIX CORPORATION (US) | 2018-08-16 | — | — | WO | disclosed |
| EP-3080613-A1 | DIFFERENTIAL DIAGNOSIS OF LIVER DISEASE | The Regents of the University of California (US) | 2016-10-19 | — | — | EP | disclosed |
| WO-2015089102-A1 | DIFFERENTIAL DIAGNOSIS OF LIVER DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-06-18 | — | — | WO | disclosed |
| CN-104335049-A | P-cresol sulphate as biomarker for healthy aging | NESTEC SA | 2015-02-04 | — | — | CN | disclosed |
| CN-104321651-A | Hydroxy-sphingomyelin 22:1 as biomarker for healthy ageing | NESTEC SA | 2015-01-28 | — | — | CN | disclosed |
| CN-104285150-A | 1-o-alkyl-2-acylglycerophosphocholine (pc-o) 40:1 as biomarker for healthy ageing | NESTEC SA | 2015-01-14 | — | — | CN | disclosed |
| CN-104204810-A | Phenylacetylglutamine as biomarker for healthy ageing | NESTEC SA | 2014-12-10 | — | — | CN | disclosed |
| CN-104204809-A | 9-oxo-octadecadienoic acid (9-oxo-HODE) as biomarker for healthy aging | NESTEC SA | 2014-12-10 | — | — | CN | disclosed |
| CN-101663031-A | Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same | MARTEK BIOSCIENCES CORP | 2010-03-03 | — | — | CN | disclosed |